Methylation of the BIN1 Gene and Its Link to Breast and Prostate Cancer
Author Information
Author(s): Kuznetsova Ekaterina B, Kekeeva Tatiana V, Larin Sergei S, Zemlyakova Valeria V, Khomyakova Anastasiya V, Babenko Olga V, Nemtsova Marina V, Zaletayev Dmitry V, Strelnikov Vladimir V
Primary Institution: Research Centre for Medical Genetics, Russian Academy of Medical Sciences, Moscow, Russia
Hypothesis
The study investigates the role of BIN1 gene promoter methylation in breast and prostate cancer.
Conclusion
The BIN1 promoter CpG island shows distinct methylation patterns in cancer, which may not directly affect gene expression.
Supporting Evidence
- The BIN1 promoter CpG island was found to be methylated in 18% of breast tumors and 9% of prostate tumors.
- No methylation was detected in normal tissues or lymphocytes.
- 77% of primary breast tumors showed loss of BIN1 expression.
Takeaway
The study looks at how a specific part of a gene related to cancer is changed in breast and prostate cancer, which might help us understand cancer better.
Methodology
Methylation-sensitive arbitrarily-primed PCR and bisulphite sequencing were used to analyze methylation patterns in tumor samples.
Limitations
The study does not establish a direct functional link between methylation and BIN1 expression loss.
Participant Demographics
99 paired primary breast cancer samples and 46 primary prostate cancer samples.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website